Nicopharm Pharmaceutical Solut - CA San Diego, San Diego 92117

Nicopharm Pharmaceutical Solut entered the industry of Unclassified in 2003 and has grown to employ 1 to 4 people, generating an annual revenue of $100.000 to $499.999. The NAICS classifies this business under the code 561990, which describes it as a Unclassified. For further clarification, the SIC classifies this business under the code 7389 and described it as a Unclassified. The business provides service to the B2B market.

To acquire more information, please contact Mike Nicolaou by calling (858) 926-5877 during business hours. You can also write to the business’ Single Location at 4931 Arroyo Lindo Avenue, San Diego, California CA 92117. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .

Company: Nicopharm Pharmaceutical Solut
Representative: Mike Nicolaou
Place of Business: 4931 Arroyo Lindo Avenue, San Diego, CA 92117
Contact Number: (858) 926-5877
Type of Service: Unclassified
SIC Number: 7389
NAICS Number: 561990
Locality: Single Location
Market Type: B2B (Business to Business)
Began: 2003
Income/Year: $100.000 to $499.999
Laborers: 1 to 4
Share This Company:

Nicopharm Pharmaceutical Solut is a company operating from San Diego, California providing professional Unclassified and relevant B2B variables. It was founded in 2003 and registered with the SIC code 7389 as Unclassified, and with the NAICS code 561990 as Unclassified.

With a current employee count of 1 to 4, Nicopharm Pharmaceutical Solut has gone to report making $100.000 to $499.999 per annum on its journey towards growth. This company invites you to contact its representative Mike Nicolaou at (858) 926-5877 for related queries, or to locate its Single Location using the coordinates 32.836205,-117.218015.

The Single Location can also be found at the street address 4931 Arroyo Lindo Avenue in San Diego, California 92117 and can be engaged online through the company website at , the company Twitter , and Facebook page .